Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.475
Bid: 1.45
Ask: 1.50
Change: -0.025 (-1.67%)
Spread: 0.05 (3.448%)
Open: 1.50
High: 1.50
Low: 1.475
Prev. Close: 1.50
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

5 Dec 2022 07:00

RNS Number : 4815I
Genedrive PLC
05 December 2022
 

 

 

genedrive plc

("genedrive" or the "Company")

 

Annual Report and Accounts and date of AGM

 

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that its 2022 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.php The Notice of the 2022 Annual General Meeting ("AGM") and hard copies of the 2022 Annual Report and Accounts will be posted to shareholders on or around 5 December 2022.

 

The Company's AGM will be held at 11am on 29 December 2022 at 46 Grafton Street, Manchester M13 9XX.

 

 

For further details please contact:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOABXBDDCDGDGDD
Date   Source Headline
8th Oct 20083:19 pmRNSChange of Adviser Name
6th Oct 20087:00 amRNSPreliminary Results - October 2008
1st Sep 20087:30 amRNSEPISTEM AND ROTTAPHARM ANNOUN
31st Jul 200811:06 amRNSTrading Update
24th Jul 20088:54 amRNSEPISTEM ANNOUNCE COLLABORATIO
23rd Jun 20087:00 amRNSMASCC Conference
7th Apr 20087:01 amRNSData to be Released at AACR
1st Apr 200810:31 amRNSEpistem services for EBI
5th Mar 20084:31 pmRNSSenior Management Appointment
28th Feb 20087:30 amRNSInterim Results
12th Feb 200811:57 amRNSNotice of Results
30th Nov 20074:23 pmRNSTotal Voting Rights
28th Nov 20072:17 pmRNSAGM Statement
20th Nov 20073:32 pmRNSIssue of Equity
2nd Nov 20078:56 amRNSNotifiable Interest
2nd Nov 20078:41 amRNSNotice of AGM
23rd Oct 200710:15 amRNSDirector/PDMR Shareholding
10th Oct 20077:01 amRNSPreliminary Results
20th Sep 20077:01 amRNSResearch Update
17th Aug 20079:57 amRNSAIM Rule 26
31st Jul 20077:01 amRNSTrading Update
28th Jun 20072:16 pmRNSDirectors Shareholdings
22nd May 20077:30 amRNSResearch Update
4th Apr 20078:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.